Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression

Molecular Psychiatry

Volumn 18, Issue 2, 2013, Pages 166-173

  Bangasser, D A ^a   Reyes, B A S ^b   Piel, D ^a   Garachh, V ^a   Zhang, X Y ^a   Plona, Z M ^a   Van Bockstaele, E J ^b   Beck, S G ^a   Valentino, R J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

corticotropin releasing hormone; locus ceruleus; receptor trafficking; sex difference; stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

ANIMAL EXPERIMENT; AROUSAL; ARTICLE; CELL MEMBRANE; CELL PROTECTION; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; DENDRITE; FEMALE; GENE OVEREXPRESSION; GENE TRANSLOCATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; LOCUS CERULEUS; MALE; MENTAL DISEASE; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; STRESS;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DENDRITES; ELECTRIC STIMULATION; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; LOCUS COERULEUS; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, IMMUNOELECTRON; NEURAL PATHWAYS; NEURONS; NOREPINEPHRINE; PATCH-CLAMP TECHNIQUES; PROTEIN TRANSPORT; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEX CHARACTERISTICS; TYROSINE 3-MONOOXYGENASE;

EID: 84873057454     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2012.24     Document Type: Article

References (68)

1. Fava M, Kendler KS. Major depressive disorder. Neuron 2000; 28: 335-341.
2. Keane TM, Marshall AD, Taft CT. Posttraumatic stress disorder: Etiology, epidemiology, and treatment outcome. Annu Rev Clin Psychol 2006; 2: 161-197.
3. Kendler KS, Kessler RC, Walters EE, MacLean C, Neale MC, Heath AC et al. Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry 1995; 152: 833-842.
4. Kessler RC, McGonagle KA, Nelson CB, Hughes M, Swartz M, Blazer DG. Sex and depression in the national comorbidity survey. II: Cohort effects. J Affect Disord 1994; 30: 15-26.
5. Kessler RC. Epidemiology of women and depression. J Affect Disord 2003; 74: 5-13.
6. Vamvakopoulos NC, Chrousos GP. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. J Clin Invest 1993; 92: 1896-1902.
7. Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamicpituitary-adrenal axis and the female reproductive system: Clinical implications. Ann Intern Med 1998; 129: 229-240.
8. Vamvakopoulos NC, Chrousos GP. Hormonal regulation of human corticotropinreleasing hormone gene expression: Implications for the stress response and immune/inflammatory reaction. Endocr Rev 1994; 15: 409-420.
9. Bangasser DA, Curtis A, Reyes BA, Bethea TT, Parastatidis I, Ischiropoulos H et al. Sex differences in corticotropin-releasing factor receptor signaling and trafficking: Potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry 2010; 15: 877, 896-904.
10. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and betaendorphin. Science 1981; 213: 1394-1397.
11. Valentino RJ, Van Bockstaele E. Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol 2008; 583: 194-203.
12. Valentino RJ, Van Bockstaele EJ. Corticotropin-releasing factor: Putative neurotransmitter actions of a neurohormone. In: Pfaff AA D, Etgen A, Fahrbach S, Moss R, Rubin R (eds). Hormones, Brain and Behavior, vol. 4. Academic Press: San Diego, 2002, pp 81-102.
13. Van Bockstaele EJ, Reyes BA, Valentino RJ. The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse. Brain Res 2010; 1314: 162-174.
14. Curtis AL, Lechner SM, Pavcovich LA, Valentino RJ. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropinreleasing factor: Effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J Pharmacol Exp Ther 1997; 281: 163-172.
15. Lechner SM, Curtis AL, Brons R, Valentino RJ. Locus coeruleus activation by colon distention: Role of corticotropin-releasing factor and excitatory amino acids. Brain Res 1997; 756: 114-124.
16. Page ME, Berridge CW, Foote SL, Valentino RJ. Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress. Neurosci Lett 1993; 164: 81-84.
17. Bissette G, Klimek V, Pan J, Stockmeier C, Ordway G. Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology 2003; 28: 1328-1335.
18. Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM et al. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 1997; 154: 624-629.
19. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs low CRH/NE states. Mol Psychiatry 2002; 7: 254-275.
20. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 2000; 97: 325-330.
21. Curtis AL, Bethea T, Valentino RJ. Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor. Neuropsychopharmacology 2006; 31: 544-554.
22. Checkley S. The neuroendocrinology of depression and chronic stress. Br Med Bull 1996; 52: 597-617.
23. Kay WH, Gwirtsman HE, George DT, Ebert MH, Jimerson DC, Tomai TP et al. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: Relation to state of nutrition, adrenal function and intensity of depression. J Clin Endocrinol Met 1987; 64: 203.
24. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984; 226: 1342-1344.
25. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994; 60: 436-444.
26. Raison CL, Miller AH. When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 2003; 160: 1554-1565.
27. Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE, Vale W. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 1992; 130: 3378-3386.
28. Dirks A, Groenink L, Bouwknecht JA, Hijzen TH, Van Der Gugten J, Ronken E et al. Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations. Eur J Neurosci 2002; 16: 1751-1760.
29. Lu A, Steiner MA, Whittle N, Vogl AM, Walser SM, Ableitner M et al. Conditional CRH overexpressing mice: An animal model for stress-elicited pathologies and treatments that target the central CRH system. Mol Psychiatry 2008; 13: 989.
30. Vicentini E, Arban R, Angelici O, Maraia G, Perico M, Mugnaini M et al. Transient forebrain over-expression of CRF induces plasma corticosterone and mild behavioural changes in adult conditional CRF transgenic mice. Pharmacol Biochem Behav 2009; 93: 17-24.
31. Valentino RJ, Page ME, Van Bockstaele E, Aston-Jones G. Corticotropin-releasing factor innervation of the locus coeruleus region: Distribution of fibers and sources of input. Neuroscience 1992; 48: 689-705.
32. Crawford LK, Craige CP, Beck SG. Increased intrinsic excitability of lateral wing serotonin neurons of the dorsal raphe: A mechanism for selective activation in stress circuits. J Neurophysiol 2010; 103: 2652-2663.
33. Swinny JD, O'Farrell E, Bingham BC, Piel DA, Valentino RJ, Beck SG. Neonatal rearing conditions distinctly shape locus coeruleus neuronal activity, dendritic arborization, and sensitivity to corticotrophin-releasing factor. Int J Neuropsychopharmacol 2010; 13: 515-525.
34. Beck SG, Pan YZ, Akanwa AC, Kirby LG. Median and dorsal raphe neurons are not electrophysiologically identical. J Neurophysiol 2004; 91: 994-1005.
35. Bangasser DA, Zhang X, Garachh V, Hanhauser E, Valentino RJ. Sexual dimorphism in locus coeruleus dendritic morphology: A structural basis for sex differences in emotional arousal. Physiol Behav 2011; 103: 342-351.
36. Calizo LH, Akanwa A, Ma X, Pan YZ, Lemos JC, Craige C et al. Raphe serotonin neurons are not homogenous: Electrophysiological, morphological and neurochemical evidence. Neuropharmacology 2011; 61: 524-543.
37. Reyes BA, Fox K, Valentino RJ, Van Bockstaele EJ. Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Eur J Neurosci 2006; 23: 2991-2998.
38. Reyes BA, Valentino RJ, Van Bockstaele EJ. Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology 2008; 149: 122-130.
39. Treweek JB, Jaferi A, Colago EE, Zhou P, Pickel VM. Electron microscopic localization of corticotropin-releasing factor (CRF) and CRF receptor in rat and mouse central nucleus of the amygdala. J Comp Neurol 2009; 512: 323-335.
40. Goebel M, Fleming SM, Million M, Stengel A, Tache Y, Wang L. Mice overexpressing corticotropin-releasing factor show brain atrophy and motor dysfunctions. Neurosci Lett 2010; 473: 11-15.
41. Paladini CA, Beckstead MJ, Weinshenker D. Electrophysiological properties of catecholaminergic neurons in the norepinephrine-deficient mouse. Neuroscience 2007; 144: 1067-1074.
42. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992; 267: 1244-1252.
43. Linthorst ACE, Flachskamm C, Hopkins SJ, Hoadley ME, Labeur MS, Holsboer F et al. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine respones to a systemic inflammatory challenge. J Neurosci 1997; 17: 4448-4460.
44. Labeur MS, Arzt E, Wiegers GJ, Holsboer F, Reul JM. Long-term intracerebroventricular corticotropin-releasing hormone administration induces distinct changes in rat splenocyte activation and cytokine expression. Endocrinology 1995; 136: 2678-2688.
45. Regev L, Neufeld-Cohen A, Tsoory M, Kuperman Y, Getselter D, Gil S et al. Prolonged and site-specific over-expression of corticotropin-releasing factor reveals differential roles for extended amygdala nuclei in emotional regulation. Mol Psychiatry 2011; 16: 714-728.
46. Groenink L, Pattij T, De Jongh R, Van der Gugten J, Oosting RS, Dirks A et al. 5-HT1A receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety. Eur J Pharmacol 2003; 463: 185-197.
47. Dirks A, Groenink L, Schipholt MI, van der Gugten J, Hijzen TH, Geyer MA et al. Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotropin-releasing hormone. Biol Psychiatry 2002; 51: 583-590.
48. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW. Overproduction of corticotropin-releasing factor in transgenic mice: A genetic model of anxiogenic behavior. J Neurosci 1994; 14(5 Pt 1): 2579-2584.
49. van Gaalen MM, Stenzel-Poore MP, Holsboer F, Steckler T. Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur J Neurosci 2002; 15: 2007-2015.
50. Wood SK, Baez MA, Bhatnagar S, Valentino RJ. Social stress-induced bladder dysfunction: Potential role of corticotropin-releasing factor. Am J Physiol Regul Integr Comp Physiol 2009; 296: R1671-R1678.
51. Curtis AL, Bello NT, Valentino RJ. Evidence for functional release of endogenous opioids in the locus ceruleus during stress termination. J Neurosci 2001; 21: RC152.
52. Kawahara H, Kawahara Y, Westerink BH. The role of afferents to the locus coeruleus in the handling stress-induced increase in the release of norepinephrine in the medial prefrontal cortex: A dual-probe microdialysis study in the rat brain. Eur J Pharmacol 2000; 387: 279-286.
53. Valentino RJ, Page ME, Curtis AL. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res 1991; 555: 25-34.
54. Smagin GN, Zhou J, Harris RB, Ryan DH. CRF receptor antagonist attenuates immobilization stress-induced norepinephrine release in the prefrontal cortex in rats. Brain Res Bull 1997; 42: 431-434.
55. Koob GF. Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry 1999; 46: 1167-1180.
56. Southwick SM, Bremner JD, Rasmusson A, Morgan 3rd CA, Arnsten A, Charney DS. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry 1999; 46: 1192-1204.
57. Perry SJ, Junger S, Kohout TA, Hoare SR, Struthers RS, Grigoriadis DE et al. Distinct conformations of the corticotropin releasing factor type 1 receptor adopted following agonist and antagonist binding are differentially regulated. J Biol Chem 2005; 280: 11560-11568.
58. Rasmussen TN, Novak I, Nielsen SM. Internalization of the human CRF receptor 1 is independent of classical phosphorylation sites and of beta-arrestin 1 recruitment. Eur J Biochem 2004; 271: 4366-4374.
59. Hauger RL, Risbrough V, Oakley RH, Olivares-Reyes JA, Dautzenberg FM. Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann N Y Acad Sci 2009; 1179: 120-143.
60. Oakley RH, Olivares-Reyes JA, Hudson CC, Flores-Vega F, Dautzenberg FM, Hauger RL. Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and beta-arrestin-2 recruitment: A mechanism regulating stress and anxiety responses. Am J Physiol Regul Integr Comp Physiol 2007; 293: R209-R222.
61. Swinny JD, Valentino RJ. Corticotropin-releasing factor promotes growth of brain norepinephrine neuronal processes through Rho GTPase regulators of the actin cytoskeleton in rat. Eur J Neurosci 2006; 24: 2481-2490.
62. Cibelli G, Corsi P, Diana G, Vitiello F, Thiel G. Corticotropin-releasing factor triggers neurite outgrowth of a catecholaminergic immortalized neuron via cAMP and MAP kinase signalling pathways. Eur J Neurosci 2001; 13: 1339-1348.
63. Van Bockstaele EJ, Colago EE, Valentino RJ. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: Substrate for the co-ordination of emotional and cognitive limbs of the stress response. J Neuroendocrinol 1998; 10: 743-757.
64. Van Bockstaele EJ, Peoples J, Valentino RJ. A.E. Bennett research award. Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents. Biol Psychiatry 1999; 46: 1352-1363.
65. Van Bockstaele EJ, Bajic D, Proudfit H, Valentino RJ. Topographic architecture of stress-related pathways targeting the noradrenergic locus coeruleus. Physiol Behav 2001; 73: 273-283.
66. Van Bockstaele EJ, Colago EE, Valentino RJ. Corticotropin-releasing factorcontaining axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J Comp Neurol 1996; 364: 523-534.
67. Million M, Wang L, Stenzel-Poore MP, Coste SC, Yuan PQ, Lamy C et al. Enhanced pelvic responses to stressors in female CRF-overexpressing mice. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1429-R1438.
68. Heinrichs SC, Min H, Tamraz S, Carmouche M, Boehme SA, Vale WW. Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated. Psychoneuroendocrinology 1997; 22: 215-224.